表面活性剂给药的新方法。
Novel approaches to surfactant administration.
作者信息
Gupta Samir, Donn Steven M
机构信息
University Hospital of North Tees and Durham University, Hardwick Road, Stockton-on-Tees, Cleveland, OH TS19 8PE, UK.
出版信息
Crit Care Res Pract. 2012;2012:278483. doi: 10.1155/2012/278483. Epub 2012 Dec 3.
Abstract
Surfactant replacement therapy has been the mainstay of treatment for preterm infants with respiratory distress syndrome for more than twenty years. For the most part, surfactant is administered intratracheally, followed by mechanical ventilation. In recent years, the growing interest in noninvasive ventilation has led to novel approaches of administration. This paper will review these techniques and the associated clinical evidence.
摘要
二十多年来，表面活性剂替代疗法一直是治疗呼吸窘迫综合征早产儿的主要手段。在大多数情况下，表面活性剂通过气管内给药，随后进行机械通气。近年来，对无创通气的兴趣日益浓厚，催生了新的给药方法。本文将综述这些技术及相关临床证据。
相似文献
1
Novel approaches to surfactant administration.
Crit Care Res Pract. 2012;2012:278483. doi: 10.1155/2012/278483. Epub 2012 Dec 3.
2
Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome.
Cochrane Database Syst Rev. 2004(3):CD003063. doi: 10.1002/14651858.CD003063.pub2.
3
Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for RDS.
Cochrane Database Syst Rev. 2002(2):CD003063. doi: 10.1002/14651858.CD003063.
4
Less invasive surfactant administration versus endotracheal surfactant instillation followed by limited peak pressure ventilation in preterm infants with respiratory distress syndrome in China: study protocol for a randomized controlled trial.
Trials. 2020 Jun 11;21(1):516. doi: 10.1186/s13063-020-04390-3.
5
Administration of surfactant using less invasive techniques as a part of a non-aggressive paradigm towards preterm infants.
Early Hum Dev. 2014 Sep;90 Suppl 2:S57-9. doi: 10.1016/S0378-3782(14)50015-1.
6
Surfactant for Respiratory Distress Syndrome: New Ideas on a Familiar Drug with Innovative Applications.
Neonatology. 2017;111(4):408-414. doi: 10.1159/000458466. Epub 2017 May 25.
7
8
Efficacy of a new technique - INtubate-RECruit-SURfactant-Extubate - "IN-REC-SUR-E" - in preterm neonates with respiratory distress syndrome: study protocol for a randomized controlled trial.
Trials. 2016 Aug 18;17:414. doi: 10.1186/s13063-016-1498-7.
9
Surfactant and noninvasive ventilation.
Neonatology. 2015;107(4):330-6. doi: 10.1159/000381122. Epub 2015 Jun 5.
10
Lung ultrasound in preterm infants with respiratory distress: experience in a neonatal intensive care unit.
Eur J Pediatr. 2020 Jan;179(1):81-89. doi: 10.1007/s00431-019-03470-0. Epub 2019 Oct 26.
引用本文的文献
1
Storage and in-use stability of an excipient enhanced growth (EEG) synthetic lung surfactant powder formulation.
Drug Dev Ind Pharm. 2025 Jul;51(7):747-757. doi: 10.1080/03639045.2025.2508845. Epub 2025 May 26.
2
Efficacy and safety of surfactant administration by MIST and INSURE techniques in Neonates with Respiratory Distress Syndrome: A randomized controlled trial.
Pak J Med Sci. 2023 May-Jun;39(3):848-852. doi: 10.12669/pjms.39.3.7283.
3
Surfactant Administration Through Laryngeal or Supraglottic Airways (SALSA): A Viable Method for Low-Income and Middle-Income Countries.
Front Pediatr. 2022 Mar 16;10:853831. doi: 10.3389/fped.2022.853831. eCollection 2022.
4
Alternative Methods of Surfactant Administration in Preterm Infants with Respiratory Distress Syndrome: State of the Art.
Turk Arch Pediatr. 2021 Nov;56(6):553-562. doi: 10.5152/TurkArchPediatr.2021.21240.
5
Surfactant therapy via thin catheter in preterm infants with or at risk of respiratory distress syndrome.
Cochrane Database Syst Rev. 2021 May 10;5(5):CD011672. doi: 10.1002/14651858.CD011672.pub2.
6
Development and Characterization of Excipient Enhanced Growth (EEG) Surfactant Powder Formulations for Treating Neonatal Respiratory Distress Syndrome.
AAPS PharmSciTech. 2021 Apr 15;22(4):136. doi: 10.1208/s12249-021-02001-1.
7
Performance of Low Air Volume Dry Powder Inhalers (LV-DPI) when Aerosolizing Excipient Enhanced Growth (EEG) Surfactant Powder Formulations.
AAPS PharmSciTech. 2021 Apr 15;22(4):135. doi: 10.1208/s12249-021-01998-9.
8
A novel delivery system for supraglottic atomization allows increased lung deposition rates of pulmonary surfactant in newborn piglets.
Pediatr Res. 2020 May;87(6):1019-1024. doi: 10.1038/s41390-019-0696-x. Epub 2019 Nov 30.
9
Delivery and performance of surfactant replacement therapies to treat pulmonary disorders.
Ther Deliv. 2013 Aug;4(8):951-80. doi: 10.4155/tde.13.72.
本文引用的文献
1
Administration of rescue surfactant by laryngeal mask airway: lessons from a pilot trial.
Am J Perinatol. 2013 Mar;30(3):201-6. doi: 10.1055/s-0032-1323592. Epub 2012 Aug 14.
2
Laryngeal mask airway for babies: uncharted waters.
Resuscitation. 2011 Nov;82(11):1373-4. doi: 10.1016/j.resuscitation.2011.08.016. Epub 2011 Sep 3.
3
Laryngeal mask airway surfactant administration for prevention of morbidity and mortality in preterm infants with or at risk of respiratory distress syndrome.
Cochrane Database Syst Rev. 2011 Jul 6(7):CD008309. doi: 10.1002/14651858.CD008309.pub2.
4
Myth: mechanical ventilation is a therapeutic relic.
Semin Fetal Neonatal Med. 2011 Oct;16(5):275-8. doi: 10.1016/j.siny.2011.04.007. Epub 2011 May 28.
5
Pharyngeal instillation of surfactant before the first breath for prevention of morbidity and mortality in preterm infants at risk of respiratory distress syndrome.
Cochrane Database Syst Rev. 2011 Mar 16(3):CD008311. doi: 10.1002/14651858.CD008311.pub2.
6
Preliminary evaluation of a new technique of minimally invasive surfactant therapy.
Arch Dis Child Fetal Neonatal Ed. 2011 Jul;96(4):F243-8. doi: 10.1136/adc.2010.192518. Epub 2010 Oct 21.
7
An open label, pilot study of Aerosurf® combined with nCPAP to prevent RDS in preterm neonates.
J Aerosol Med Pulm Drug Deliv. 2010 Oct;23(5):303-9. doi: 10.1089/jamp.2009.0758.
8
Surfactant without intubation in preterm infants with respiratory distress: first multi-center data.
Klin Padiatr. 2010 Jan-Feb;222(1):13-7. doi: 10.1055/s-0029-1241867. Epub 2010 Jan 18.
9
Surface active drugs significantly alter the drug output rate from medical nebulizers.
Int J Pharm. 2010 Jan 15;384(1-2):128-36. doi: 10.1016/j.ijpharm.2009.10.012. Epub 2009 Oct 13.
10
Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome.
Cochrane Database Syst Rev. 2007 Oct 17;2007(4):CD003063. doi: 10.1002/14651858.CD003063.pub3.
Zotero 插件